Hépatite C : Soins nutritionnels - SOS hépatites

Bibliographie par chapitre21. Abe Y, Ueda T, Kato T et al : Effectiveness of Interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C.Nippon Rinsho (Japanese J Clin Med) 1994; 52(7):1817–182222. Okuno T, Arai K, Shindo M : Efficacy of Interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant tointerferon therapy. Nippon Rinsho (Japanese J Clin Med) 1994; 52(7):1823–182723. Tyler VE : Licorice. Dans The Honest Herbal : A Sensible Guide to the Use of Herbs and Related Remedies, 3 e éd. Binghamton,NY : Pharmaceutical Products Press, 1993:197–19924. Davydov VV, Molokovskii DS, Limarenko AI : Efficacy of ginseng drugs in experimental insulin-dependent diabetes and toxichepatitis. Patologicheskaia Fiziologiia i Eksperimentalnaia Terapiia 1990; (5):49–5225. Jeong TC, Kim HJ, Park JI et al : Protective effects of red ginseng saponins against carbon tetrachloride-induced hepatotoxicityin Sprague Dawley rats. Planta Medica 1997; 63(2):136–14026. Matsuda H, Samukawa K, Kubo M : Anti-hepatitic activity of ginsenoside ro. Planta Medica 1991; 57(6):523–52627. Zuin M, Battezzati, PM, Camisasca M et al : Effects of a preparation containing a standardized ginseng extract combined withtrace elements and multivitamins against hepatotoxin-induced chronic liver disease in the elderly. J Intl Med Res 1987; 15(5):276–28128. Tyler VE : Ginseng and related herbs. Dans The Honest Herbal : A Sensible Guide to the Use of Herbs and Related Remedies, 3 eéd. Binghamton, NY : Pharmaceutical Products Press, 1993:153–15829. Philipp M, Kohnen R, Hiller KO : Hypericum extract versus imipramine or placebo in patients with moderate depression :randomised multicentre study of treatment for eight weeks. Br Med J 1999; 319(7224):1534–153930. Liu JP, Manheimer E, Tsutani K et al : Medicinal herbs for hepatitis C virus infection. [Review] Cochrane Database Syst Rev2001; (4):CD00318331. Stern E : Two cases of hepatitis C treated with herbs and supplements. J Alternat & Complement Med 1997; 3(1):77–8232. Kemeny ME, Gruenewald TL : Psychoneuroimmunology update. [Review] Seminars in Gastrointestinal Disease 1999; 10(1):20–2933. Cohen MR : Herbal and complementary and alternative medicine therapies for liver disease. A focus on Chinese traditionalmedicine in hepatitis C virus. [Review] Clin Liver Dis 2001; 5(2):461–478, viiBibliographie du chapitre 71. Comité directeur conjoint pour la préparation d’un plan d’action national sur la nutrition : La nutrition pour un virage santé :voies d’action. Comité directeur conjoint, Ottawa, 19962. Dieterich DT : Hepatitis C virus and human immunodeficiency virus : clinical issues in co-infection. Am J Med 1999;107(6B):79S–84S3. Remis RS : Estimating the Number of Persons Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus in Canada,Rapport final à la Division de l’hépatite C, Direction générale de la santé de la population et de la santé publique, Santé Canada,mars 20014. Walmsley S, Heathcote J (co-présidents du groupe d’experts) : Lignes directrices de prise en charge pour l'adulte co-infecté parle VHC/VIH, recommandations d'un groupe d'experts multidisciplinaire. Rapport final à Santé Canada, 31 octobre 20005. Association Canadienne pour l’étude du foie : La prise en charge de l’hépatite virale, compte rendu d’une conférence deconcertation, Montréal (Québec), mars 19996. American Dietetic Association, Dietitians of Canada : Manual of Clinical Dietetics, 6 e éd., ADA et DC, octobre 2000(chapitre 32 : HIV/AIDS)7. American Dietetic Association, Dietitians of Canada : Nutrition intervention in the care of persons with human immunodeficiencyvirus infection. Position of the American Dietetic Association and Dietitians of Canada. J Am Diet Assoc 2000; 100:708–7178. Fried MW : Management of hepatitis C in the hemophilia patient. Am J Med 1999; 107(6B):85S–89S9. Eyster MF, Alter HJ, Aledort LM et al : Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiencydeficiency virus (HIV). Ann Intern Med 1991; 115(10):764–76810. Ghany MG, Leissinger C, Lagier R et al : Effect of human immunodeficiency virus infection on hepatitis C virus infection inhemophiliacs. Dig Dis Sci 1996; 41:1265–127211. Macias J, Pineda JA, Leal MA et al : Influence of hepatitis C infection on the mortality of anti-retroviral-treated patients with HIVdisease. Eur J Clin Microbiol Infect Dis 1998; 17:167–17012. Bruno R, Sacchi P, Puoti M et al : HCV chronic hepatitis in patients with HIV : clinical management issues. Am J Gastroenterol2002; 97(7):1598–160613. Sulkowski MS, Moore RD, Mehta SH et al : Hepatitis C and progression of HIV disease. JAMA 2002; 288(2):199–20614. Rossi SJ, Volberding PA, Wright TL : Does hepatitis C virus infection increase the risk of HIV disease progression? [Comment]JAMA 2002; 288(2):241–24315. American Dietetic Association, Dietitians of Canada : Manual of Clinical Dietetics, 6 e éd., ADA et DC, octobre 2000(chapitre 20 : Diabetes Mellitus)16. Mason AL, Lau JY, Hoang N et al : Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29(2):328–33317. Mehta SH, Strathdee SA, Thomas DL : Association between hepatitis C virus infection and diabetes mellitus. [Review] EpidemiolRev 2001; 23(2):302–312Hépatite C : Soins nutritionnelsLignes directrices canadiennes pour les intervenants de la santé55